Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
about
Treating the elderly diabetic patient: special considerationsMetformin combined with acarbose vs. single medicine in the treatment of type 2 diabetes: A meta-analysisTranslational potential of a mouse in vitro bioassay in predicting gastrointestinal adverse drug reactions in Phase I clinical trials.Pharmacological treatment of obesity in patients with polycystic ovary syndrome.Use of hypoglycemic drugs during lactation.Transcriptomic analysis of insulin-sensitive tissues from anti-diabetic drug treated ZDF rats, a T2DM animal model.Efficacy of sitagliptin when added to ongoing therapy in korean subjects with type 2 diabetes mellitusPhysiological Changes in Older Adults and Their Effect on Diabetes Treatment.Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients.Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study.Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes.Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin.Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic Mice.Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin.Linagliptin plus metformin: a pharmacokinetic and pharmacodynamic evaluation.Efficacy and safety of Jentadueto® (linagliptin plus metformin).The importance of synthetic drugs for type 2 diabetes drug discovery.Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity.Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug release.Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes.Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes.Design and In-vitro Evaluation of Sustained Release Floating Tablets of Metformin HCl Based on Effervescence and Swelling.Glucose homeostasis is impaired by a paradoxical interaction between metformin and insulin in carnivorous rainbow trout.The Role of Eif6 in Skeletal Muscle Homeostasis Revealed by Endurance Training Co-expression Networks.Investigation of the Role of a Supplementation with Taurine on the Effects of Hypoglycemic-Hypotensive Therapy Against Diabetes-Induced Nephrotoxicity in Rats.Pharmacokinetics of metformin in the rat: assessment of the effect of hyperlipidemia and evidence for its metabolism to guanylurea.Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes.Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes.Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.Development of liquid chromatographic method for the simultaneous determination of metformin and miglitol in human plasma: application to pharmacokinetic studiesEthyl Cellulose Microparticles Containing Metformin HCl by Emulsification-Solvent Evaporation Technique: Effect of Formulation VariablesA comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats
P2860
Q26995176-BD6DE541-CF1C-4163-B492-B585653D120FQ33744996-F407F1EB-DE18-4850-94CD-A875D5326B51Q34392292-4C958F20-DA29-4118-BB48-4D782FA28D9FQ34442683-850F1100-FC8E-4512-89D0-2C308146A62EQ34606503-FDE64D17-D2D0-46B7-A780-D819BA1053CCQ34903312-176403D9-DA6E-41F9-A34D-95C40DEA67E2Q35228228-BE264F28-9182-4EC2-BE07-AD505374B3C2Q35910471-B6B7C07A-FAFB-4B71-A438-E03A90EDF9B3Q36144000-125F6FAE-1923-445D-80CB-345911D21241Q36223890-63CD0642-BB61-43B1-8722-0E8BFB9AFA14Q36324890-89581316-A82B-4E2D-B58B-ED275ABB2D3FQ36437420-D92073F0-50E5-4859-9426-B2C08FE0183EQ36812821-E9EAB477-BB57-42B4-889D-449C095E4DCCQ36847318-4A9C56DA-39C3-4D3B-B0F3-D1FC387DD5E5Q37063273-052B7416-1A29-46AD-9ECB-9D4B3B9D1A33Q37779779-33767F89-90CE-48CB-843E-878BCE83D0BCQ38078436-FCDA37FC-8509-45E2-B343-F73D1D55528BQ38082848-C8FEA428-3CE8-4C76-B163-F4A1E100AA31Q38139508-8A0608B0-7DDF-43F6-8A82-9E8FB8E711C9Q38647822-02153907-5DBA-4076-AE02-4D89616E5AA9Q38673914-85438F99-8470-4FE0-A396-00A17AAF9F01Q38975736-EAE34F45-9350-4C69-8BA2-67FF440EE2E6Q39052682-620700E9-ABB6-48B7-A3C0-82B1AAE5BD5DQ39379908-48839432-6438-4DA6-ADDB-7042D06EADBEQ40880873-BFC9A82A-D4FB-4B8A-9148-5A77E6E16479Q42354624-3E28D6CE-E007-4BC0-9EC6-A1A3F2DFB5F1Q43268961-437707E9-35F4-402F-9FC0-5408C0153F0FQ47118511-D16D0453-98B5-41CF-8528-5F7B454E60CEQ47890276-DBF1985F-929B-4B54-AE0E-3F0974700909Q50904722-6E66C22E-38F6-4B64-865F-BB9A05A7FD71Q51365744-E5F61FD7-898E-4C56-8232-FE6A476695D1Q51369410-04C85639-837C-4E59-B9A1-56AA95D116FEQ51478110-A36E7E0A-A7C1-4C29-8286-D8F3AB2E8BB6Q56035502-681E3E9A-E81A-4CB0-AD1B-DFC56C1FD1EAQ58692464-F5306039-57DC-4E88-8CC1-C497D9055ED0Q58792938-22C1F1F8-E417-400F-8C2C-2E433338514A
P2860
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Metformin hydrochloride in the ...... with a focus on dual therapy.
@ast
Metformin hydrochloride in the ...... with a focus on dual therapy.
@en
type
label
Metformin hydrochloride in the ...... with a focus on dual therapy.
@ast
Metformin hydrochloride in the ...... with a focus on dual therapy.
@en
prefLabel
Metformin hydrochloride in the ...... with a focus on dual therapy.
@ast
Metformin hydrochloride in the ...... with a focus on dual therapy.
@en
P2093
P1476
Metformin hydrochloride in the ...... with a focus on dual therapy.
@en
P2093
Jason L Iltz
Jason Thams
R Keith Campbell
Stephen M Setter
P304
P356
10.1016/S0149-2918(03)90089-0
P577
2003-12-01T00:00:00Z